Synthesis and anticancer activity of aminodihydroquinoline analogs: Identification of novel proapoptotic agents

Bioorganic and Medicinal Chemistry Letters

Volumn 23, Issue 13, 2013, Pages 3976-3978

  Lee, Eun ^a   Han, Seulaa ^a   Jin, Guo Hua ^a   Lee, Hwa Jin ^a   Kim, Woo Young ^a   Ryu, Jae Ha ^a   Jeon, Raok ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

Aminodihydroquinoline; Anticancer activity; Cytotoxicity

Indexed keywords

AMINODIHYDROQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COMPETITIVE INHIBITION; CYTOTOXICITY; DRUG SYNTHESIS; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; METASTASIS; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; QUINOLINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84878852055     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2013.04.038     Document Type: Article

References (9)

1. R. Siegel, D. Naishadham, and A. Jemal CA Cancer J. Clin. 62 2012 10
2. J.H. Atkins, and L.J. Gershell Nat. Rev. Drug Disc. 1 2002 491
3. G. Schwartsmann, M.J. Ratain, G.M. Cragg, J.E. Wong, N. Saijo, D.R. Parkinson, Y. Fujiwara, R. Pazdur, D.J. Newman, R. Dagher, and L. Di Leone J. Clin. Oncol. 20 2002 47S
4. S. Jaroch, P. Holscher, H. Rehwinkel, D. Sulzle, G. Burton, M. Hillmann, and F.M. McDonald Bioorg. Med. Chem. Lett. 13 2003 1981
5. J. Fotie, M. Kaiser, D.A. Delfin, J. Manley, C.S. Reid, J.M. Paris, T. Wenzler, L. Maes, K.V. Mahasenan, C. Li, and K.A. Werbovetz J. Med. Chem. 53 2010 966
6. S. He, A. Dayton, P. Kuppusamy, K.A. Werbovetz, and M.E. Drew Antimicrob. Agents Chemother. 56 2012 2428
7. S. Chen, L. Chen, N.T. Le, C. Zhao, A. Sidduri, J.P. Lou, C. Michoud, L. Portland, N. Jackson, J.J. Liu, F. Konzelmann, F. Chi, C. Tovar, Q. Xiang, Y. Chen, Y. Wen, and L.T. Vassilev Bioorg. Med. Chem. Lett. 17 2007 2134
8. M.H. Hsu, C.J. Chen, S.C. Kuo, J.G. Chung, Y.Y. Lai, C.M. Teng, S.L. Pan, and L.J. Huang Eur. J. Pharmacol. 559 2007 14
9. The cell cycle and dying cells were analyzed as described previously (Tate, C. R.; Rhodes, L. V.; Segar, H. C.; Driver, J. L.; Pounder, F. N.; Burow, M. E.; Collins-Burow, B. M. Breast Cancer Res. 2012, 14, R79). Briefly, the cells with or without the drug treatment were fixed with EtOH and the nuclear DNA were labeled by propidium iodide. The cells with different DNA amount were analyzed by FACS Calibur (BD Biosciences, San Jose, CA).